Oncology & Cancer

Many men not told pros, cons of PSA testing, survey finds

(HealthDay)—Many doctors insulate their patients from the complexities surrounding the PSA test, and instead decide on their own whether to screen for prostate cancer or not, a new study finds.

Oncology & Cancer

Expert panel suggests PSA test may benefit some men

(HealthDay) -- Men with a life expectancy of more than 10 years should talk with their doctor about getting a prostate-specific antigen (PSA) test for prostate cancer, an expert panel recommends.

Oncology & Cancer

Final advice: Panel against routine prostate test

Healthy men shouldn't get routine prostate cancer screenings, says updated advice from a government panel that found the PSA blood tests do more harm than good.

Oncology & Cancer

A new screening method for prostate cancer

A new study by NYU Langone Medical Center and Northwestern University Feinberg School of Medicine shows novel PSA velocity (PSAV) risk count testing may provide a more effective way for physicians to screen men for clinically ...

Oncology & Cancer

How microchips could help detect prostate cancer

Professor of Electronic Engineering Andrew Flewitt is working with researchers at the Cancer Research UK (CRUK) Cambridge Centre on a more accurate PSA blood test to detect prostate cancer.

page 3 from 4